121.21  20.35 (20.18%)		07-31 16:00
Open: 100.46 High: 123.5 Volume: 2,355,408		Pre. Close: 100.86 Low: 99.52 Market Cap: 4,116(M)

Short term
Mid term
Targets	6-month :	144.24	1-year :	168.48
Resists	First :	123.5	Second :	144.24
Pivot price	99.13
Supports	First :	102.93	Second :	90.23
MAs	MA(5) :	104.33	MA(20) :	97.45
	MA(100) :	90.06	MA(250) :	89.03
MACD	MACD :	3.8	Signal :	2.1
%K %D	K(14,3) :	90.7	D(3) :	89.3
RSI	RSI(14): 83.4
52-week	High :	123.5	Low :	62

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ ITGR ] has closed above the upper band by 38.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 280.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 11 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	123.65 - 124.11	124.11 - 124.48
Low:	98.5 - 98.97	98.97 - 99.36
Close:	120.35 - 121.23	121.23 - 121.95

Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.

Sat, 01 Aug 2026
Integer Holdings Corporation Revenue Breakdown – NYSE:ITGR - TradingView

Fri, 31 Jul 2026
Integer Holdings jumps as investors appear to refocus on strategic review and takeover potential - Quiver Quantitative

Fri, 31 Jul 2026
Integer Holdings Corporation (ITGR) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com

Fri, 31 Jul 2026
ITGR Stock Jumps As Analysts Boost Price Targets - StocksToTrade

Fri, 31 Jul 2026
KKR nearing deal to buy medical device firm Integer, WSJ reports - Reuters

Fri, 31 Jul 2026
Integer Holdings Shares Surge on WSJ Report of Possible Acquisition by KKR - marketscreener.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Devices
Shares Out	34 (M)
Shares Float	33 (M)
Held by Insiders	1.3 (%)
Held by Institutions	119.3 (%)
Shares Short	4,350 (K)
Shares Short P.Month	4,540 (K)

EPS	4.03
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	49.99
Profit Margin	7.6 %
Operating Margin	8.1 %
Return on Assets (ttm)	4.2 %
Return on Equity (ttm)	8.5 %
Qtrly Rev. Growth	0.5 %
Gross Profit (p.s.)	14.65
Sales Per Share	54.78
EBITDA (p.s.)	10.68
Qtrly Earnings Growth	0 %
Operating Cash Flow	190 (M)
Levered Free Cash Flow	98 (M)

PE Ratio	30.07
PEG Ratio	2.6
Price to Book value	2.42
Price to Sales	2.21
Price to Cash Flow	21.7

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.